StockNews.com Initiates Coverage on Nabriva Therapeutics (NASDAQ:NBRV)
StockNews.com assumed coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note released on Monday. The firm issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance The firm has a market capitalization of $45.46 million, a P/E ratio of -0.07 and a beta of 1.53. Nabriva Therapeutics […]
20 Sep 01:52 · The Cerbat Gem